Kohl Schwartz, A.S.; Burkard, S; Mitter, V.R.; Leichtle, A.B.; Fink, A.; von Wolff, M. (2020). Short-term application of ibuprofen before ovulation. Facts, views & vision in ObGyn, 12(3), pp. 179-184. Flemish Society of Obstetrics & Gynaecology
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
short_term_application_.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (294kB) | Request a copy |
Aim of the study
The aim was to analyse if ibuprofen, as a non-selective cyclooxygenase (COX) inhibitor, has any negative effect on oocyte competence and embryo quality. COX- inhibitors are popular over-the-counter analgesics. Whereas selective COX inhibitors have been shown to impair female fertility, data on non-selective COX inhibitors are poor. Hence, they have not been recommended for women trying to conceive.
Methods
This is an observational study comparing ibuprofen exposed and unexposed women from 18 to 42 years of age, using the model of natural cycle in vitro fertilisation (IVF) to determine oocyte and embryo quality. Follicular growth was monitored and if the follicle was mature (≥ 15mm size and estimated oestradiol level of ≥ 800pmol/l), ovulation was triggered. Women with luteinising hormone (LH) surge received 400mg ibuprofen every 8 hours to postpone ovulation, whereas women without LH surge received none (controls). Oocyte retrieval rate, oocyte maturity, fertilization rate, embryo development and embryo quality as well as implantation rate were analysed.
Results
Of the 111 women included, 63 received ibuprofen, and 48 did not. Rates of mature oocytes and implantation rate did not differ. Logistic regression showed no significant association of ibuprofen intake, LH- level or reason for infertility on embryo quality.
Conclusion
Based on our results, we suggest that, particularly within natural cycle IVF, ibuprofen does no harm around ovulation as analgesic treatment.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry |
UniBE Contributor: |
Kohl Schwartz, Alexandra, Mitter, Vera Ruth, Leichtle, Alexander Benedikt (B), Fink, Anja, von Wolff, Michael |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2032-0418 |
Publisher: |
Flemish Society of Obstetrics & Gynaecology |
Language: |
English |
Submitter: |
Karin Balmer |
Date Deposited: |
21 Dec 2020 09:13 |
Last Modified: |
02 Mar 2023 23:34 |
PubMed ID: |
33123693 |
Uncontrolled Keywords: |
IVF Iboprufen implantation rate natural cycle IVF non-steroidal anti-inflammatory drug ovulation |
BORIS DOI: |
10.7892/boris.148721 |
URI: |
https://boris.unibe.ch/id/eprint/148721 |
Actions (login required)
 |
Edit item |